Information displayed below is a subset of the entire knowledge base and may be incorrect, or incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.

Description

Essential thrombocythemia (ET) is a rare type of blood cancer that affects the production of platelets in the bone marrow. It is a chronic disorder that causes the body to produce too many platelets, which can lead to an increased risk of blood clots. Symptoms of ET can include headaches, dizziness, fatigue, and shortness of breath. Treatment for ET typically involves medications to reduce the number of platelets in the blood, as well as lifestyle changes to reduce the risk of blood clots.

Synonyms

• essential hemorrhagic thrombocythemia
• essential thrombocytosis
• idiopathic hemorrhagic thrombocythemia
• idiopathic thrombocythemia
• primary thrombocythemia
• primary thrombocytosis

Basic Lab Tests (measurements)

• plasma
  •      antithrombin
  •      thrombopoietin
  •      protein S
• serum
  •      vitamin B12
  •      interleukin-6
  •      beta-2-microglobulin
  •      lysozyme
  •      uric acid
  •      interleukin-2
  •      lactate dehydrogenase
  •      TNF-alpha
  •      potassium
  •      phosphate
• whole blood
  •      platelets
  •      mean corpuscular volume
  •      neutrophils
  •      mean corpuscular hemoglobin
  •      leukocytes
  •      microcytes
  •      hemoglobin F
  •      hypersegmented neutrophils
  •      macrocytes
  •      granulocytes

Detailed Disease and Condition Information (use the search buttons below to find details on these topics)
All of the following must be considered when interpreting clinical findings and are too extensive to be covered on this site: